Partnership Opportunities
Our goal is to create partnerships with companies to help minimize their investment risk by providing the research environment, expertise, clinical samples and joint funding to conduct the preclinical and early-stage clinical research necessary to find treatments that would otherwise be ignored in the traditional for-profit, drug-development process. We see this as a revolutionary business model that will accelerate access to treatment for pediatric patients.
Potential partnerships are available in these areas:
Therapeutics
- ADHD
- Asthma
- Bone Disorders and Malformations
- Brain Cancers
- Brain Injury and Disorders – Neurovascular Imaging
- Brain Malformations
- Brain Tumors – New Targets and Drugs
- Cancer, Inherited and Infectious Disease – Cell Transduction
- Cancer – Costimulatory Receptors to Advance Immunotherapy
- Cancer – Drugs for Sarcoma
- Cancer – Epigenetic Profiling Tools
- Cancer – Identifying New Vulnerabilities in Treatment-Resistant AML
- Cancer – Leukemias
- Cancer – Leukemias
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Nanoparticles for Precision Drug Delivery
- Cancer – Neurotoxicity
- Cancer – Psychosocial Biomarkers
- Cancer – Switch Receptors to Advance Immunotherapy
- Cancer – T cell conditioning
- Cancer – Target Validation
- CAR T Cell Optimization
- CAR T Cell Optimization – De-Risking Therapies
- Cell and Gene Therapies
- Cerebellar Development
-
Chronic Inflammatory Conditions – Novel Therapies
- Chronic Pain
- Combination Therapies for Pediatric Medulloblastoma
- Concussion
- Congenital Disorders – Genetic Testing
- Congenital Disorders of Glycosylation
- Congenital Heart Defects – Zebrafish Models
- Craniofacial Malformations – Clinical Data
- Cryptosporidium and Other Parasites
- Duchenne Muscular Dystrophy – Zebrafish Models
- Engineered Cell Therapies
- Epilepsy – Drug Screening
- Epilepsy – Gene Therapy
- Epilepsy – Stem Cell Models
- Fibrosis
- Fibrosis – Models for Regenerative Medicine
- Group B Streptococcus
- Heart Arrhythmia
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemophilia – Immunomodulation Therapy
- Hemophilia – Intraosseous Lentiviral Therapy
- HIV – CAR-T therapies
- HIV – Diagnostics
- HIV – Viral Reservoirs
- HIV – Transmission and Progression
- Hypoplastic Left Heart Syndrome
- Infantile Hemangiomas and Other Vascular Malformations
- Infectious Diseases – Drug Discovery by Advanced Computational Methods
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Inflammatory Bowel Disease – Dietary Modifications
- Influenza – Vaccines
- Kawasaki Disease
- Lung Diseases – Bacteriophage Therapies
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Malaria – Human Immune Response
- Malaria – Molecular Mechanisms
- Malaria – Next-Generation Therapeutics
- Malaria – Vaccines, Therapies, Drug Resistance
- Medulloblastoma – Studies With Stem Cells
- Mitochondrial Diseases – Identifying Therapies
- Motor Impairments and Paralysis
- Nanobodies – Diagnostic and Therapeutic Resources
- Neural Development and Neurodegeneration
- Nontuberculous Mycobacterial Diseases – Drug Discovery
- Obesity – Chimeric Peptide Therapeutics
- Opioid Sensitivity and Tolerance
- Optimizing CAR T Cells at the Level of Receptor Signaling
- Pain
-
Pathogenic Protein Degradation
- Peroxisomal Disorders
- Retinal Disorders
- Rheumatic Diseases
- Schizophrenia – New Drugs
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Drug Discovery
- Tuberculosis – Drug Regimens
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis, Nontuberculous Mycobacterial Diseases – Nanoparticle-Delivered Therapy
- Vascular and Lymphatic Malformations – Genotyping and Treatment
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Diagnostics
- Autism and Fragile X Syndrome — Signal Transduction and Therapeutics
- Cancer – Improving Immunotherapy
- Cancer – Leukemias
- Cancer – Leukemias
- Cancer – Neurotoxicity
- Concussion
- Congenital Disorders – Genetic Testing
- Healthcare Associated Infections
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Immunoreactivity and Tolerance
- HIV – Diagnostics
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Infantile Hemangiomas and Other Vascular Malformations
- Kawasaki Disease
- Juvenile Idiopathic Arthritis
- Lupus – B-Cell Targets
- Nanobodies – Diagnostic and Therapeutic Resources
- Retinal Disorders
- Sepsis
- Sleep Apnea
- Tuberculosis and Antimicrobial-Resistance
- Vascular and Lymphatic Malformations – Genotyping and Treatment
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Medical Devices
- Craniofacial Malformations – Clinical Data
- Epilepsy – Medical Device Interventions
- Heart Arrhythmia
- Hemophilia – Gene Therapy
- Hypoplastic Left Heart Syndrome
- Juvenile Idiopathic Arthritis
- Lung Diseases – Bacteriophage Therapies
- Malaria – Automated Insect Dissection Tool
- Motor Impairments and Paralysis
- Sleep Apnea
- Tuberculosis, Nontuberculous Mycobacterial Diseases – Nanoparticle-Delivered Therapy
Vaccines
- Group B Streptococcus
- HIV – Transmission and Progression
- Infectious Diseases – Immune Development
- Influenza – Vaccines
- Lung Diseases – Bacteriophage Therapies
- Malaria – Human Immune Response
- Malaria – Vaccines, Therapies, Drug Resistance
- Tuberculosis
- Tuberculosis, Nontuberculous Mycobacterial Diseases – Nanoparticle-Delivered Therapy
Research Tools and Understanding Disease Pathways
- Anesthesia Risks
- Autism and Fragile X Syndrome – Signal Transduction and Therapeutics
- Asthma
- Bone Disorders and Malformations
- Brain Injury and Disorders – Neurovascular Imaging
- Brain Overgrowth Diseases
- Brain Malformations
- Brain Tumor Research Lab
- Brain Tumors – Neurotrophin Receptors
- Breathing Dysregulation
- Cancer – Epigenetic Profiling Tools
- Cancer – Identifying New Vulnerabilities in Treatment-Resistant AML
- Cancer, Inherited, and Infectious Disease – Cell Transduction
- Cancer – Leukemias
- Cancer – Leukemias
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neurotoxicity
- Cancer – Target Validation
- CAR T Cell Optimization
- CAR T Cell Optimization – De-Risking Therapies
- Cell and Gene Therapies
- Cerebellar Development
- Combination Therapies for Pediatric Medulloblastoma
- Congenital Disorders – Genetic Testing
- Congenital Disorders of Glycosylation
- Congenital Heart Defects – Zebrafish Models
- Cryptosporidium and Other Parasites
- Duchenne Muscular Dystrophy – Zebrafish Models
- Engineered Cell Therapies
- Epilepsy – Drug Screening
- Epilepsy – Stem Cell Models
- Fibrosis
- Fibrosis – Models for Regenerative Medicine
- Food Insecurity and Chronic Disease Management
- Healthcare Associated Infections
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- HIV Microbiomes
- HIV – Transmission and Progression
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Hypoplastic Left Heart Syndrome
- Infectious Diseases – Drug Discovery by Advanced Computational Methods
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Influenza – Vaccines
- Juvenile Idiopathic Arthritis
- Lung Diseases – Bacteriophage Therapies
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Malaria – Automated Insect Dissection Tool
- Malaria – Human Immune Response
- Malaria – Molecular Mechanisms
- Malaria – Vaccines, Therapies, Drug Resistance
- Medulloblastoma – Studies With Stem Cells
- Mitochondrial Disease
- Mitochondrial Diseases – Identifying Therapies
- MRSA Infections
- Neural Development and Neurodegeneration
- Nontuberculous Mycobacterial Diseases – Drug Discovery
- Obesity – Chimeric Peptide Therapeutics
- Opioid Sensitivity and Tolerance
- Optimizing CAR T Cells at the Level of Receptor Signaling
- Organ Development
- Osteosarcoma – Biomaterials for Tumor Modeling and Bone Regrowth
- Peroxisomal Disorders
- Retinal Disorders
- Rheumatic Diseases
- Sepsis
- Sleep Apnea
- Stroke
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Drug Discovery
- Tuberculosis – Drug Regimens
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis and Antimicrobial-Resistance
- Vascular and Lymphatic Malformations – Genotyping and Treatment
- Viral Diseases – Improving RNA-Seq
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Educational Products and Digital Health
- Activity and Fitness
- ADHD
- Adolescent-Focused Digital Health Interventions
- Inflammatory Bowel Disease – Dietary Modifications
- Pain
Learn More
To learn more about partnering with Seattle Children’s Research Institute, or if you’re a Seattle Children’s researcher looking for industry partners, please email the Office of Science-Industry Partnerships.